Deal Could Transform Kyphon (RealMoney.com $)
The medical-device maker's acquisition sends shares soaring.
10:46AM 12/08/06
Abbott Labs Is Positioned for Improved Growth
Opportunities include stents, Humira, diabetic treatments, and cholesterol drugs.
09:50AM 12/05/06
The latest surprising setback may lead to some strategic reverberations.
07:50AM 12/05/06
Pfizer's Worst-Case Scenario (RealMoney.com $)
The setback may lead to some strategic reverberations.
02:04PM 12/04/06
Expectations Deflated for Alkermes
The company's alcohol-treatment drug did not have the expected impact.
03:17PM 12/01/06
Expectations Deflated for Alkermes (RealMoney.com $)
The company's alcohol-treatment drug did not have the expected impact.
10:29AM 12/01/06
Defibrillator Boost May Recharge Greatbatch (RealMoney.com $)
A rebound in defibrillators is good for this small-cap.
10:07AM 11/29/06
J&J's Conor Buy Props Up Its Lead (RealMoney.com $)
The deal is a smart move to stay a major player in the drug-eluting device market.
08:18AM 11/21/06
Shop Carefully for Generic-Drug Makers (RealMoney.com $)
Their stocks have fallen, but there's good reason for the lower prices. Still, two players offer promise.
10:45AM 11/15/06
Dendreon's Risks Will Yield Rewards
The biotech firm's bold strategy with the FDA on its cancer vaccine is likely to pay off.
07:42AM 11/15/06


RSS Feed
Connect with TheStreet